Hull J H, Hak L J, Koch G G, Wargin W A, Chi S L, Mattocks A M
Clin Pharmacol Ther. 1981 Apr;29(4):516-21. doi: 10.1038/clpt.1981.72.
Several formulas for predicting creatinine clearance (Ccr) are used for adjusting drug dosages but limited data are available on their accuracy in patients with significant renal impairment or concurrent disease. We measured 144 Ccr in 103 patients and compared results using four predictive methods. Of nine common diseases in these patients, liver disease was associated with a large (p less than 0.02) prediction error (overprediction). After data from eight patients with liver disease were removed, there was good overall correlation between predicted and measured Ccr (r2 = 0.91 for each method) but only two of the methods (I and IV) were consistently accurate in all ranges of renal function. Methods for predicting Ccr should not be used in patients with liver disease.
有几种预测肌酐清除率(Ccr)的公式用于调整药物剂量,但关于这些公式在严重肾功能损害或合并疾病患者中的准确性的数据有限。我们对103例患者的144次Ccr进行了测量,并使用四种预测方法比较了结果。在这些患者的九种常见疾病中,肝病与较大的(p<0.02)预测误差(高估)相关。在剔除八例肝病患者的数据后,预测的Ccr与测量的Ccr之间总体相关性良好(每种方法的r2 = 0.91),但只有两种方法(I和IV)在所有肾功能范围内都始终准确。预测Ccr的方法不应在肝病患者中使用。